Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 3

1(33.3%)

3Total

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT03465254Unknown

Dengue Serostatus Study in the Philippines

Role: collaborator

NCT05014373Phase 3Unknown

Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19

Role: collaborator

NCT01255436Not ApplicableCompleted

Effectiveness of SMS Text Reminders to Improve Blood Pressure Among Patients With Hypertension

Role: collaborator

NCT00229775Not ApplicableCompleted

Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines

Role: collaborator

All 4 trials loaded